Daniel Jackson, MD, and James Gern, MD, Receive NIH Supplemental Funding

Congratulations to Daniel Jackson, MD, Principal Investigator, and James Gern, MD, Co-Principal Investigator, for their 9-month supplemental funding on Inner City Asthma Consortium (ICAC3). The $401,456 supplement from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) is titled, “The effects of allergen associated type-2 inflammation and particulate matter inflammation in the airway epithelium on SARS-CoV-2 infection.” In collaboration with Matthew Altman, MD (Benaroya Institute) and Jason Debley, MD (Seattle Children’s Hospital), the team plans to define the contributions of underlying allergic inflammation and pollution exposure to the susceptibility and airway immune response to SARS-CoV-2 infection.